AstraZeneca's COVID-19 vaccination program

AstraZeneca’s COVID-19 vaccination program used a vaccine developed with Oxford University, designed to stimulate the immune system to recognize and fight the virus. It is administered in two doses, spaced weeks apart, and is known for being more affordable and easier to store than some other vaccines. The program aimed to provide broad protection against COVID-19, reduce illness severity, and help control the pandemic globally. While it has been effective for many, some concerns about rare side effects have prompted careful monitoring and guidelines for its use.